The arterial organ in cardiovascular disease: ADAPT (arterial disease assessment, prevention, and treatment) clinic

被引：15

作者：

O'Brien, E ^{[1
]}

Bouchier-Hayes, D ^{[1
]}

Fitzgerald, D ^{[1
]}

Atkins, N ^{[1
]}

机构：

[1] Beaumont Hosp, Blood Pressure Unit, Dublin 9, Ireland

来源：

LANCET | 1998年 / 352卷 / 9141期

关键词：

D O I：

10.1016/S0140-6736(97)09026-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1700 / 1702

页数：3

共 13 条

[1] COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS
ALTMAN, R
CARRERAS, L
DIAZ, R
FIGUEROA, E
PAOLASSO, E
PARODI, JC
CADE, JF
DONNAN, G
EADIE, MJ
GAVAGHAN, TP
OSULLIVAN, EF
PARKIN, D
RENNY, JTG
SILAGY, C
VINAZZER, H
ZEKERT, F
ADRIAENSEN, H
BERTRANDHARDY, JM
BRAN, M
DAVID, JL
DRICOT, J
LAVENNEPARDONGE, E
LIMET, R
LOWENTHAL, A
MORIAU, M
SCHAPIRA, S
SMETS, P
SYMOENS, J
VERHAEGHE, R
VERSTRAETE, M
ATALLAH, A
BARNETT, H
BATISTA, R
BLAKELY, J
CAIRNS, JA
COTE, R
CROUCH, J
EVANS, G
FINDLAY, JM
GENT, M
LANGLOIS, Y
LECLERC, J
NORRIS, J
PINEO, GF
POWERS, PJ
ROBERTS, R
SCHWARTZ, L
SICURELLA, J
TAYLOR, W
THEROUX, P
[J]. BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921): : 81 - 100
[2] Atkins N, 1998, J HYPERTENS, V16, pS198
[3] CAST: Randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke
Chen, ZM
Hui, JM
Liu, LS
Liu, ZM
Peto, R
Sandercock, P
Wang, WQ
Wang, YX
Wang, ZB
Xie, JX
You, GX
Zhang, FL
Zhang, HQ
Zhao, ZY
[J]. LANCET, 1997, 349 (9066) : 1641 - 1649
[4] Mortality rates in treated hypertensive men with additional risk factors are high but can be reduced - A randomized intervention study
Fagerberg, B
Wikstrand, J
Berglund, G
Samuelsson, O
Agewall, S
[J]. AMERICAN JOURNAL OF HYPERTENSION, 1998, 11 (01) : 14 - 22
[5] Gensini GF, 1998, EUR HEART J, V19, pA53
[6] Plasma homocysteine as a risk factor for vascular disease - The European concerted action project
Graham, IM
Daly, LE
Refsum, HM
Robinson, K
Brattstrom, LE
Ueland, PM
PalmaReis, RJ
Boers, GHJ
Sheahan, RG
Israelsson, B
Uiterwaal, CS
Meleady, R
McMaster, D
Verhoef, P
Witteman, J
Rubba, P
Bellet, H
Wautrecht, JC
deValk, HW
Luis, ACS
ParrotRoulaud, FM
Tan, KS
Higgins, I
Garcon, D
Medrano, MJ
Candito, M
Evans, AE
Andria, G
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (22): : 1775 - 1781
[7] Cardiovascular risk in hypertension: implications of the Sheffield Table for lipid-lowering strategy
Hasnain, S
Webster, J
McLay, JS
[J]. JOURNAL OF HUMAN HYPERTENSION, 1998, 12 (07) : 469 - 471
[8] MOHER M, 1997, BMJ-BRIT MED J, V515, P69
[9] The rationale for differing national recommendations for the treatment of hypertension
Ramsay, LE
Wallis, EJ
Yeo, WM
Jackson, PR
[J]. AMERICAN JOURNAL OF HYPERTENSION, 1998, 11 (06) : 79S - 88S
[10] The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
Sacks, FM
Pfeffer, MA
Moye, LA
Rouleau, JL
Rutherford, JD
Cole, TG
Brown, L
Warnica, JW
Arnold, JMO
Wun, CC
Davis, BR
Braunwald, E
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (14) : 1001 - 1009

← 1 2 →